![Insights from 2024 EHA Annual Meeting](http://media.vumedi.com/thumbs/channel_logo/2024/6/8d846ca9-a80f-4328-885e-a4302b90cd59.png.200x0_q85.png)
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: SYMPATICO Study - Ibrutinib + Venetoclax in MCL With TP53 Mutations
By
Insights from 2024 EHA Annual Meeting
FEATURING
Wojciech Jurczak
By
Insights from 2024 EHA Annual Meeting
FEATURING
Wojciech Jurczak
Login to view comments.
Click here to Login